Ranking results:

Past rankings:

2020
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	700-800
2019
Criterium:	Position:
Overall Score:	500-600
Total Project Funding per Partner:	> 1000
Total Number of Projects:	300-400
2018
Criterium:	Position:
Overall Score:	> 1000
Total Project Funding per Partner:	> 1000
Total Number of Projects:	> 1000
Networking Rank (Reputation):	> 1000
2016
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

Project Participation Performance(2016-01-01 - 2023-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 32
As coordinator: 0
As participant: 32
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2022	0	2.473.985	270.331		1
2021	0	45.736.990	264.207		5
2020	0	85.107.848	252.788		5
2019	0	68.205.073	516.996		9
2018	0	15.942.861	0		2
2017	0	55.675.195	0		6
2016	0	33.556.083	463.820		4

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
NOVARTIS PHARMA	13
PFIZER LIMITED	13
BAYER	10
JANSSEN PHARMACEUTICA NV	10
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	8
ABBVIE INC	7
F HOFFMANNLA ROCHE	7
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V	7
LEIDS UNIVERSITAIR MEDISCH CENTRUM	7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	7
UCB BIOPHARMA	7
UNIVERSITY OF DUNDEE	7
ASTRAZENECA	6
KATHOLIEKE UNIVERSITEIT LEUVEN	6
NOVO NORDISK	6
SANOFIAVENTIS	6
ELI LILLY AND COMPANY LIMITED	5
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	5
INSTITUT DE RECHERCHES SERVIER	5
UNIVERSITAET BERN	5
UNIVERSITEIT MAASTRICHT	5
ASTRAZENECA AB	4
EUROPEAN MOLECULAR BIOLOGY LABORATORY	4
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	4
MEDIZINISCHE UNIVERSITAET WIEN	4
UNIVERSITAT WIEN	4
UNIVERSITE DU LUXEMBOURG	4
UNIVERSITY OF HELSINKI	4
ACADEMISCH ZIEKENHUIS GRONINGEN	3
ASTELLAS PHARMA EUROPE BV	3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS	3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH	3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	3
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM	3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER	3
JDRF INTERNATIONAL	3
LUND UNIVERSITY	3
MEDIZINISCHE UNIVERSITAT INNSBRUCK	3
MERCK SHARP & DOHME CORP	3
SANOFIAVENTIS DEUTSCHLAND	3
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT	3
STICHTING LYGATURE	3
STICHTING VUMC	3
TAKEDA PHARMACEUTICALS INTERNATIONAL	3
TECHNISCHE UNIVERSITAET MUENCHEN	3
THE UNIVERSITY OF LIVERPOOL	3
UNIVERSITAETSKLINIKUM FREIBURG	3
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT	3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ	3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	3
AB ENZYMES	2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM	2
ALLERGAN LIMITED	2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	2
BAYER AKTIENGESELLSCHAFT	2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE	2
CERTARA UK LIMITED	2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL	2
CONCENTRIS RESEARCH MANAGEMENT	2
EBERHARD KARLS UNIVERSITAET TUEBINGEN	2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE	2
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS	2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE	2
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA	2
IKTOS	2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE	2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT	2
KAROLINSKA INSTITUTE	2
LEIDEN UNIVERSITY	2
LINKOPINGS UNIVERSITET	2
LIPOTYPE	2
LONZA	2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN	2
MEDTRONIC INTERNATIONAL TRADING SARL	2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE	2
ORION OYJ	2
OULUN YLIOPISTO	2
OWKIN FRANCE	2
PSYCHOGENICS INC	2
RIJKSUNIVERSITEIT GRONINGEN	2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE	2
STATENS LEGEMIDDELVERK	2
STICHTING BURO ECNP	2
STICHTING KATHOLIEKE UNIVERSITEIT	2
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM	2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL	2
TAKEDA DEVELOPMENT CENTRE EUROPE	2
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	2
THE UNIVERSITY OF EDINBURGH	2
THE UNIVERSITY OF EXETER	2
THE UNIVERSITY OF MANCHESTER	2
THE UNIVERSITY OF NOTTINGHAM	2
THE UNIVERSITY OF TUEBINGEN	2
TRANSGENE	2
TTOPSTART BV	2
UNIVERSITA CATTOLICA DEL SACRO CUORE	2
UNIVERSITAET BASEL	2
UNIVERSITAET GREIFSWALD	2
UNIVERSITAET ZU LUEBECK	2

Constancy:

Total number of partners: 737
Partner loyalty:
Frequent Partner: (> 2 projects): 249
Rare Partner: 488
Frequent / Rare Partner Ratio: 0.51

Project overview:

Start date	Project	acronym	role	funding	partners
2022-09-01	Greener, more sustainable platforms for high-value recombinant protein production	greenerRPP	participant	2.473.985	15
2021-07-01	Real World Handling of Protein Drugs - Exploration, Evaluation and Education	RealHOPE	participant	3.139.984	27
2021-06-01	Psychiatric Ratings using Intermediate Stratified Markers 2	PRISM 2	participant	3.980.906	18
2021-03-01	Deconstructing the evolution of metastasis	Evomet	participant	4.014.435	15
2021-02-01	Central Repository for Digital Pathology	BIGPICTURE	participant	32.319.825	51
2021-01-01	Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials	SISAQOL-IMI	participant	2.281.840	33
2020-06-01	Stratification of Obesity Phenotypes to Optimize Future Therapy	SOPHIA	participant	8.301.000	36
2020-05-01	EUbOPEN: Enabling and Unlocking biology in the OPEN	EUbOPEN	participant	27.935.000	23
2020-04-01	Corona Accelerated R&D in Europe	CARE	participant	36.559.186	43
2020-01-01	INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.	INSPIRE	participant	4.021.969	11
2020-01-01	PharmaLedger	PharmaLedger	participant	8.290.694	30
2019-12-01	Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies	imSAVAR	participant	10.999.316	28
2019-09-01	Proton transport and proton-coupled transport	PROTON	participant	3.976.976	12
2019-09-01	Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials	Trials@Home	participant	19.036.998	33
2019-06-01	MachinE Learning Ledger Orchestration for Drug DiscoverY	MELLODDY	participant	8.000.000	17
2019-05-01	ENdoThelial macRophage Alliance In Neuroinflammation	ENTRAIN	participant	3.664.174	20
2019-04-01	Thrombo-inflammation in cardiovascular disease	TICARDIO	participant	3.944.038	10
2019-04-01	Biomarkers in Atopic Dermatitis and Psoriasis	BIOMAP	participant	10.500.000	32
2019-01-01	FAIRplus	FAIRplus	participant	3.996.150	22
2019-01-01	A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes	Secreters	participant	4.087.421	16
2018-12-01	Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe	EUROoC	participant	3.942.861	21
2018-07-01	Research empowerment on solute carriers (ReSOLUTE)	ReSOLUTE	participant	12.000.000	14
2017-11-01	Liver Investigation: Testing Marker Utility in Steatohepatitis	LITMUS	participant	15.797.881	56
2017-10-01	European Quality In Preclinical Data	EQIPD	participant	4.495.523	30
2017-09-01	Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management	eTRANSAFE	participant	20.000.000	27
2017-09-01	Targeting the metabolism-immune system connections in Cancer	META-CAN	participant	3.831.958	20
2017-02-01	Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055	DO-IT	participant	3.549.833	36
2017-01-01	Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030	TransQST	participant	8.000.000	23
2016-09-01	Biomarker Enterprise to Attack DKD - Sofia ref.: 115974	BEAt-DKD	participant	15.085.937	31
2016-04-01	Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916	PRISM	participant	8.080.000	23
2016-03-01	Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924	VAC2VAC	participant	7.850.000	23
2016-01-01	Big Data in Chemistry	BIGCHEM	participant	2.540.146	17

Alias institution names:

BOEHRINGER INGELHEIM INTERNATIONALGMBH
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
BOEHRINGER INGELHEIM RCV GMBH & CO KG
BOEHRINGER INGELHEIM VETMEDICA

BOEHRINGER INGELHEIM PHARMA GMBH &CO KG -